We are live on !
Find out more
Cetera Advisors Portfolio holdings
AUM
$12.7B
Turnover
31.41%
1-Year Est. Return
22.7%
This Fund
S&P 500
This Quarter Est. Return
+8.74%
1 Year Est. Return
+22.7%
3 Year Est. Return
+27.57%
5 Year Est. Return
+84.51%
10 Year Est. Return
+153.37%
AUM
$12.7B
AUM Growth
+$5.47B
(+76%)
Cap. Flow
+$4.76B
Cap. Flow % of AUM
Cap. Flow %
37.54%
Top 10 Holdings %
Top 10 Hldgs %
18.38%
Holding
2,499
New
711
Increased
1,442
Reduced
226
Closed
74
Avg Time Held
Equity + Options
2.6
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.7
years
Avg Time Held Equity only
2.6
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$201M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$150M |
| 3 |
Microsoft
MSFT
|
+$115M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$111M |
| 5 |
NVIDIA
NVDA
|
+$85.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$60.5M |
| 2 |
iShares Russell Mid-Cap ETF
IWR
|
+$7.89M |
| 3 |
FT Vest US Equity Enhance & Moderate Buffer ETF March
XMAR
|
+$7.32M |
| 4 |
FT Vest US Equity Moderate Buffer ETF February
GFEB
|
+$6.14M |
| 5 |
Pacer Global Cash Cows Dividend ETF
GCOW
|
+$5.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.49% |
| 2 | Technology | 11.25% |
| 3 | Financials | 5.19% |
| 4 | Consumer Discretionary | 4.46% |
| 5 | Healthcare | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2351
DELISTED
Luminar Technologies
LAZR
| $33.4K | ﹤0.01% |
1,130
+39
| +4% | +$1.42K |
2023 Q4
1 quarter
|
|
2352
Veru
VERU
$38M
| $33.1K | ﹤0.01% |
+4,734
| New | +$25.2K |
2024 Q1
0 quarters
|
|
2353
Humacyte
HUMA
$121M
| $31.4K | ﹤0.01% |
+10,105
| New | +$34K |
2024 Q1
0 quarters
|
|
2354
Gold Royalty Corp
GROY
$656M
| $31.2K | ﹤0.01% |
+16,615
| New | +$26.7K |
2024 Q1
0 quarters
|
|
|
SOL
2355
DELISTED
Emeren Group
SOL
| $31.1K | ﹤0.01% |
16,095
| – | – |
2021 Q1
12 quarters
|
|
2356
ThredUp
TDUP
$260M
| $30.9K | ﹤0.01% |
15,433
-16,816
| -52% | -$34.3K |
2023 Q4
1 quarter
|
|
2357
Opko Health
OPK
$1.23B
| $30.6K | ﹤0.01% |
25,500
+12,000
| +89% | +$12K |
2021 Q4
9 quarters
|
|
|
MIN
2358
Aberdeen Intermediate Income Fund
MIN
$266M
| $30.3K | ﹤0.01% |
1,896
+34
| +2% | +$557 |
2023 Q1
4 quarters
|
|
2359
PUT
CrowdStrike
CRWD
$264B
| $28.3K | ﹤0.01% |
5,200
-5,600
| -52% | -$429K |
2023 Q4
1 quarter
|
|
2360
Lumen Technologies, Inc. Common Stock
LUMN
$4.7B
| $27.8K | ﹤0.01% |
+17,822
| New | +$27.8K |
2024 Q1
0 quarters
|
|
2361
DELISTED
Tellurian Inc.
TELL
| $26.8K | ﹤0.01% |
+40,518
| New | +$27.5K |
2024 Q1
0 quarters
|
|
2362
Platinum Group Metals
PLG
$136M
| $26.7K | ﹤0.01% |
+22,828
| New | +$24.5K |
2024 Q1
0 quarters
|
|
2363
Lexicon Pharmaceuticals
LXRX
$632M
| $25.6K | ﹤0.01% |
+10,675
| New | +$22.9K |
2024 Q1
0 quarters
|
|
2364
DELISTED
Checkpoint Therapeutics
CKPT
| $25.4K | ﹤0.01% |
+12,366
| New | +$24.7K |
2024 Q1
0 quarters
|
|
2365
DELISTED
WW International
WW
| $24.2K | ﹤0.01% |
+13,097
| New | +$52.1K |
2024 Q1
0 quarters
|
|
2366
Kopin
KOPN
$610M
| $23.4K | ﹤0.01% |
13,027
| – | – |
2022 Q1
8 quarters
|
|
2367
Virgin Galactic
SPCE
$373M
| $21K | ﹤0.01% |
+710
| New | +$25.8K |
2024 Q1
0 quarters
|
|
2368
PUT
Global X Uranium ETF
URA
$4.79B
| $20.9K | ﹤0.01% |
20,900
+800
| +4% | +$23.2K |
2023 Q3
2 quarters
|
|
2369
Phio Pharmaceuticals
PHIO
$9.9M
| $20.7K | ﹤0.01% |
+3,380
| New | +$23.3K |
2024 Q1
0 quarters
|
|
2370
BlackSky Technology
BKSY
$719M
| $20.4K | ﹤0.01% |
+1,877
| New | +$20.6K |
2024 Q1
0 quarters
|
|
|
AMLI
2371
DELISTED
American Lithium Corp. Common Stock
AMLI
| $19.1K | ﹤0.01% |
28,089
-8,200
| -23% | -$6.98K |
2023 Q2
3 quarters
|
|
2372
PUT
Cameco
CCJ
$34.2B
| $18.5K | ﹤0.01% |
+12,700
| New | +$557K |
2024 Q1
0 quarters
|
|
2373
Milestone Pharmaceuticals
MIST
$80.5M
| $18.5K | ﹤0.01% |
+10,326
| New | +$16.8K |
2024 Q1
0 quarters
|
|
2374
DELISTED
Vaxart
VXRT
| $17.7K | ﹤0.01% |
13,605
-4,895
| -26% | -$5.13K |
2022 Q1
8 quarters
|
|
2375
DELISTED
Danimer Scientific, Inc.
DNMR
| $16.5K | ﹤0.01% |
+378
| New | +$15.7K |
2024 Q1
0 quarters
|
|
Similar funds
Cetera Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Cetera Advisors held 2,499 positions worth $12.7B, up 76% from $7.22B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cetera Advisors deployed $4.76B of net new capital in Q1 2024, opening 711 new positions and adding to 1,442 existing holdings. Its largest new stake was BlackRock US Equity Factor Rotation ETF: 641,610 shares worth $28.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, down from 67% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Goldman Sachs ActiveBeta US Large Cap Equity ETF, an estimated $60.5M trimmed.
- Cetera Advisors's largest Q1 2024 buy was BlackRock US Equity Factor Rotation ETF: 641,610 shares worth $28.5M.
- Cetera Advisors added most to Apple in Q1 2024, an estimated $201M increase.
- Cetera Advisors's biggest Q1 2024 reduction was Goldman Sachs ActiveBeta US Large Cap Equity ETF, cutting an estimated $60.5M.
- Cetera Advisors fully exited FT Vest US Equity Buffer & Premium Income ETF September in Q1 2024, selling an estimated $4.38M.
- Cetera Advisors's ten largest holdings make up 18% of its $12.7B portfolio in Q1 2024.
- Cetera Advisors opened 711 new positions and closed 74 in Q1 2024.
- Cetera Advisors's portfolio value rose 76% quarter-over-quarter to $12.7B.
Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.